Study on the effectiveness of COVID-19 measures in the Netherlands The measures implemented in the Netherlands during the COVID-19 crisis were effective against the spread of the SARS-CoV-2 virus. This is the outcome of a study conducted by RIVM.
Continuing significant increase in young adults with gonorrhoea The number of people in the Netherlands with gonorrhoea is continuing to increase significantly. Diagnosed cases of this sexually transmitted infection increased by 31% in 2023, compared to 2022. These cases involved people who were tested at a sexual health centre operated by the Municipal Public Health Services (GGDs).
Nitrogen and nature approach shows progress towards 2030, but targets are out of reach The nitrogen and nature measures that the government has implemented since 2021 are expected to make a positive contribution to the future quality of nature. The average exceedance of the critical loads for nitrogen deposition will decrease by a third up to 2030.
Increase in STI consultations in 2023, rise in gonorrhoea cases persists The number of consultations for sexually transmitted infections (STIs) at Sexual Health Centres (SHCs) was higher in the first half of 2023 compared to the previous year. Notably, the number of gonorrhoea cases continues to rise.
Natura 2000 sites: nitrogen deposition on the decline, but still too high for much of nature The amount of nitrogen deposited on nature reserves that are vulnerable to this is falling. However, this decline is not sufficient to meet the targets the Dutch government has set itself. This is the conclusion of the RIVM monitoring report ‘Nitrogen deposition in Natura 2000 areas 2023’.
Participation rates in cancer population screening programmes continue to decline The number of participants in the population screening programmes for breast cancer, cervical cancer and colorectal cancer continues to decline. This decline has been going on for years, reaching its lowest point in 2020.
Metabolic disorder ALD added to newborn blood spot screening Since 1 October, the metabolic disorder adrenoleukodystrophy (ALD) has been added to the Dutch newborn blood spot screening. From now on, the blood of newborn boys will also be tested for this disorder. ALD in boys can be treated if it is detected in time.
More STIs diagnosed in 2022, most significant increase in gonorrhoea More people got tested for an STI at Sexual Health Centres (SHCs) in 2022 than in 2021. There were a total of 164,715 consultations at SHCs. The percentage of people found to have an STI (21%) was also higher than in 2021.
Municipal Public Health Services once again conduct more STI consultations than before COVID-19 The number of STI consultations at the Sexual Health Centres of the Municipal Public Health Services (GGDs) was 19% higher in 2022 compared to 2021.
From 1 October 2023, heel prick test also screens for metabolic disorder ALD From 1 October 2023, the blood of newborn babies will also be tested for the metabolic disorder adrenoleukodystrophy (ALD). This is done with the heel prick screening test.